These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 1438241

  • 1. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies.
    Luo L, Li Y, Cannon PM, Kim S, Kang CY.
    Proc Natl Acad Sci U S A; 1992 Nov 01; 89(21):10527-31. PubMed ID: 1438241
    [Abstract] [Full Text] [Related]

  • 2. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar 01; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R.
    Virology; 1997 Aug 18; 235(1):26-39. PubMed ID: 9300034
    [Abstract] [Full Text] [Related]

  • 9. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
    Wagner R, Böltz T, Deml L, Modrow S, Wolf H.
    J Gen Virol; 1993 Jul 18; 74 ( Pt 7)():1261-9. PubMed ID: 7687647
    [Abstract] [Full Text] [Related]

  • 10. Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles.
    Wagner R, Deml L, Schirmbeck R, Niedrig M, Reimann J, Wolf H.
    Virology; 1996 Jun 01; 220(1):128-40. PubMed ID: 8659105
    [Abstract] [Full Text] [Related]

  • 11. Assembly and immunogenicity of chimeric Gag-Env proteins derived from the human immunodeficiency virus type 1.
    Truong C, Brand D, Mallet F, Roingeard P, Brunet S, Barin F.
    AIDS Res Hum Retroviruses; 1996 Mar 01; 12(4):291-301. PubMed ID: 8906989
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion.
    Griffiths JC, Harris SJ, Layton GT, Berrie EL, French TJ, Burns NR, Adams SE, Kingsman AJ.
    J Virol; 1993 Jun 01; 67(6):3191-8. PubMed ID: 8497047
    [Abstract] [Full Text] [Related]

  • 17. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L, Kratochwil G, Osterrieder N, Knüchel R, Wolf H, Wagner R.
    Virology; 1997 Aug 18; 235(1):10-25. PubMed ID: 9300033
    [Abstract] [Full Text] [Related]

  • 18. Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes.
    Park EJ, Vujcic LK, Anand R, Theodore TS, Quinnan GV.
    J Virol; 1998 Sep 18; 72(9):7099-107. PubMed ID: 9696803
    [Abstract] [Full Text] [Related]

  • 19. Use of the recombinant chimera proteins, LacZ-Env and Gag-Env, for immunological studies on HIV-1 infection.
    Morimoto M, Saitoh A, Ueba N, Nakata A, Shinagawa H.
    AIDS Res Hum Retroviruses; 1993 Oct 18; 9(10):971-8. PubMed ID: 7506555
    [Abstract] [Full Text] [Related]

  • 20. Restriction of serum antibody reactivity to the V3 neutralizing domain of HIV gp120 with progression to AIDS.
    Page M, Vella C, Corcoran T, Dilger P, Ling C, Heath A, Thorpe R.
    AIDS; 1992 May 18; 6(5):441-6. PubMed ID: 1616648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.